[TROP] QoQ Annualized Quarter Result on 30-Sep-2017 [#3]

Stock
[TROP] TROPICANA CORPORATION BERHAD
Announcement Date
30-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- -5.62%
YoY- 45.12%
Quarter Report
Latest QR
Upcoming QR
TROP's Result
TROP's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 1,468,866 1,812,020 1,908,768 1,719,638 1,652,526 1,494,728 1,459,405 0.43%
PBT 300,814 341,768 291,766 236,702 256,972 162,192 168,053 47.58%
Tax -111,422 -132,936 -91,778 -69,736 -78,310 -49,088 -53,052 64.22%
NP 189,392 208,832 199,988 166,966 178,662 113,104 115,001 39.58%
-
NP to SH 168,806 185,612 190,475 161,144 170,732 108,232 112,537 31.13%
-
Tax Rate 37.04% 38.90% 31.46% 29.46% 30.47% 30.27% 31.57% -
Total Cost 1,279,474 1,603,188 1,708,780 1,552,672 1,473,864 1,381,624 1,344,404 -3.25%
-
Net Worth 3,379,201 3,337,397 3,301,337 3,245,233 3,221,417 2,867,748 3,126,514 5.33%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 46,811 93,681 29,215 38,981 58,306 - 35,690 19.88%
Div Payout % 27.73% 50.47% 15.34% 24.19% 34.15% - 31.71% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 3,379,201 3,337,397 3,301,337 3,245,233 3,221,417 2,867,748 3,126,514 5.33%
NOSH 1,470,417 1,470,417 1,470,417 1,465,761 1,465,761 1,465,761 1,447,466 1.05%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 12.89% 11.52% 10.48% 9.71% 10.81% 7.57% 7.88% -
ROE 5.00% 5.56% 5.77% 4.97% 5.30% 3.77% 3.60% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 100.41 123.79 130.67 117.64 113.37 104.24 102.23 -1.19%
EPS 11.54 12.68 13.10 11.11 11.80 7.56 7.87 29.15%
DPS 3.20 6.40 2.00 2.67 4.00 0.00 2.50 17.94%
NAPS 2.31 2.28 2.26 2.22 2.21 2.00 2.19 3.63%
Adjusted Per Share Value based on latest NOSH - 1,465,761
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 63.92 78.85 83.06 74.83 71.91 65.05 63.51 0.43%
EPS 7.35 8.08 8.29 7.01 7.43 4.71 4.90 31.13%
DPS 2.04 4.08 1.27 1.70 2.54 0.00 1.55 20.15%
NAPS 1.4705 1.4523 1.4367 1.4122 1.4019 1.248 1.3606 5.32%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 0.855 0.89 0.915 0.94 0.97 1.00 1.00 -
P/RPS 0.85 0.72 0.70 0.80 0.86 0.96 0.98 -9.07%
P/EPS 7.41 7.02 7.02 8.53 8.28 13.25 12.69 -30.20%
EY 13.50 14.25 14.25 11.73 12.08 7.55 7.88 43.31%
DY 3.74 7.19 2.19 2.84 4.12 0.00 2.50 30.90%
P/NAPS 0.37 0.39 0.40 0.42 0.44 0.50 0.46 -13.54%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 23/08/18 22/05/18 28/02/18 30/11/17 29/08/17 26/05/17 27/02/17 -
Price 0.88 0.885 0.895 0.90 0.95 0.965 0.985 -
P/RPS 0.88 0.71 0.68 0.77 0.84 0.93 0.96 -5.65%
P/EPS 7.63 6.98 6.86 8.16 8.11 12.78 12.50 -28.10%
EY 13.11 14.33 14.57 12.25 12.33 7.82 8.00 39.12%
DY 3.64 7.23 2.23 2.96 4.21 0.00 2.54 27.19%
P/NAPS 0.38 0.39 0.40 0.41 0.43 0.48 0.45 -10.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment